Efficacy of molnupiravir and sotrovimab in Japanese dialysis patients with <scp>COVID</scp>‐19 in clinical practice during the Omicron (<scp>BA</scp>.1 and <scp>BA</scp>.2) pandemic
- DOI
- 10.1111/1744-9987.14033
- Published
- 2023-07-03
- Container
- Therapeutic Apheresis and Dialysis
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/1744-9987.14033,
title = {Efficacy of molnupiravir and sotrovimab in Japanese dialysis patients with <scp>COVID</scp>‐19 in clinical practice during the Omicron (<scp>BA</scp>.1 and <scp>BA</scp>.2) pandemic},
author = {Kan Kikuchi and Masaomi Nangaku and Munekazu Ryuzaki and Tomoyuki Yamakawa and Yoshihiro Ota and Norio Hanafusa and Ken Sakai and Yoshihiko Kanno and Ryoichi Ando and Toshio Shinoda and Shu Wakino and Hidetomo Nakamoto and Yoshiaki Takemoto and Tadao Akizawa and Unknown},
year = {2023},
journal = {Therapeutic Apheresis and Dialysis},
doi = {10.1111/1744-9987.14033},
url = {https://doi.org/10.1111/1744-9987.14033}
}RIS
TY - JOUR TI - Efficacy of molnupiravir and sotrovimab in Japanese dialysis patients with <scp>COVID</scp>‐19 in clinical practice during the Omicron (<scp>BA</scp>.1 and <scp>BA</scp>.2) pandemic AU - Kan Kikuchi AU - Masaomi Nangaku AU - Munekazu Ryuzaki AU - Tomoyuki Yamakawa AU - Yoshihiro Ota AU - Norio Hanafusa AU - Ken Sakai AU - Yoshihiko Kanno AU - Ryoichi Ando AU - Toshio Shinoda AU - Shu Wakino AU - Hidetomo Nakamoto AU - Yoshiaki Takemoto AU - Tadao Akizawa AU - Unknown PY - 2023 JO - Therapeutic Apheresis and Dialysis DO - 10.1111/1744-9987.14033 UR - https://doi.org/10.1111/1744-9987.14033 ER -
APA
Kikuchi, K., Nangaku, M., Ryuzaki, M., Yamakawa, T., Ota, Y., Hanafusa, N., Sakai, K., Kanno, Y., Ando, R., Shinoda, T., Wakino, S., Nakamoto, H., Takemoto, Y., Akizawa, T., & Unknown (2023). Efficacy of molnupiravir and sotrovimab in Japanese dialysis patients with <scp>COVID</scp>‐19 in clinical practice during the Omicron (<scp>BA</scp>.1 and <scp>BA</scp>.2) pandemic. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14033
Source records
- crossref · retrieved 2026-09-27T03:39:01.677Z